Small peptidic aldehyde inhibitors of human rhinovirus 3C protease

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 23, 1996, Pages 2893-2896

  Shepherd, Timothy A ^a   Cox, Gregory A ^a   McKinney, Emma ^a   Tang, Joseph ^a   Wakulchik, Mark ^a   Zimmerman, Ronald E ^a   Villarreal, Elcira C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; ANTIVIRUS AGENT; CALPEPTIN; DIPEPTIDE; ENZYME INHIBITOR; LEUPEPTIN; LY 338387; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; IN VITRO STUDY; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

HUMAN RHINOVIRUS 3; HUMAN RHINOVIRUS SP.;

EID: 0030568127     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00537-9     Document Type: Article

References (20)

1. 1. Gwaltney, J. M., Jr. In Viral Infections of Humans: Epidemiology and Control, 2nd ed.; Evans, A. S., Ed.; Plenum: New York, 1982; pp 491-517.
2. 2. Palmenberg, A, C. J. Cell. Biochem. 1987, 33, 191.
3. 3. Matthews, D. A.; Smith, W. W.; Ferre, R. A.; Condon, B.; Budahazi, G.; Sisson, W.; Villafranca, J. E.; Janson, C. A.; McElroy, H. E.; Gribskow, C. L.; Worland, S. Cell 1994, 77, 761.
4. 4. Cordingley, M. G.; Callahan, P. L.; Sardana, V. V.; Garsky, V. M.; Colonno, R. J. J. Biol. Chem. 1990, 265, 9062.
5. 5. Skiles, J. W.; McNeil, D. Tetrahedron Lett. 1990, 31, 7277.
6. 6. Singh, S. B.; Cordingley, M. G.; Ball, R. G.; Smith, J. L.; Dombrowski, A. W.; Goetz, M. A. Tetrahedron Lett. 1991, 32, 5279.
7. 7. Kadam, S.; Poddig, J.; Humphrey, P.; Karwowski, J.; Jackson, M.; Tennent, S.; Fung, L.; Hochlowski, J.; Rasmussen, R.; McAlpine, J. J. Antibiotics 1994, 47, 836.
8. 8. Sham, H. L.; Rosenbrook, W.; Kati, W.; Betebenner, D. A.; Wideburg, N. E.; Saldivar, A.; Plattner, J. J.; Norbeck, D. W. J. Chem. Soc. Ferkin Trans. 1995, 63, 1081.
9. 9. Malcolm, B. A.; Lowe, C.; Schechosky, S.; McKay, R. T.; Yang, C. C.; Shah, V. J.; Simon, R. J.; Vederas, J. C.; Santi, D. V. Biochemistry 1995, 34 , 286.
10. 10. Kaldor, S. W.; Hammond, M.; Dressman, B. A.; Labus, J. M.; Chadwell, F. W.; Kline, A. D.; Heinz, B. A. Bioorg. Med. Chem. Lett. 1995, 5, 2021.
11. 50 = 300 μM. We have used an average of these reports.
12. 14
13. 13. Heinz, B. A.; Tang, J.; Labus, J. M.; Chadwell, F. W.; Kaldor, S. W.; Hammond, M. Antimicrob. Agents Chemother. 1996, 40, 267.
14. 14. Villarreal, E. C; Wakulchik, M.; Zimmerman, R. E.; Cox, G. A.; McKinney, E.; Tang, J.; Shepherd, T. A. manuscript submitted.
15. 50.
16. 16. Tsujinaka, T.; Kajiwara, Y.; Kambayashi, J.; Sakon, M.; Higuchi, N.; Tanaka, T.; Mori, T. Biochem. Biophys. Res. Commun. 1988, 753, 1201. Calpeptin was purchased from NovaBiochem.
17. 17. Woo, J-T.; Sigeizumi, S.; Yamaguchi, K.; Sugimoto, K.; Kobori, T.; Tsuji, T.; Kondo, K. Bioorg. Med. Chem. Lett. 1995, 5, 1501.
18. 18. Hodge, C. N.; Aldrich, P. E.; Fernandez, C. H.; Otto, M. J.; Rayner, M. M.; Wong, Y. N.; Erickson-Viitanen, S. Antiviral Chem. Chemother. 1994, 5, 257.
19. 6S: C, 59.18; H, 5.87; N, 6.27; Found: C, 58.98; N, 6.06; N, 6.00.
20. 20. Steve Kahl, Rob Johnson and Q. May Wang (Lilly Research Labs) private communication.